DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
EBioMedicine
Authors:
Verena Sailer, Ulrike Sailer, Emma Grace Bawden, Romina Zarbl, Constanze Wiek, Timo J Vogt, Joern Dietrich, Sophia Loick, Ingela Grünwald, Marieta Toma, Carsten Golletz, Andreas Gerstner, Glen Kristiansen, Friedrich Bootz, Kathrin Scheckenbach, Jennifer Landsberg, Dimo Dietrich
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.
Leukemia
Authors:
Laura Cicconi, Uwe Platzbecker, Giuseppe Avvisati, Francesca Paoloni, Christian Thiede, Marco Vignetti, Paola Fazi, Felicetto Ferrara, Mariadomenica Divona, Francesco Albano, Fabio Efficace, Marco Sborgia, Eros Di Bona, Massimo Breccia, Erika Borlenghi, Roberto Cairoli, Alessandro Rambaldi, Lorella Melillo, Giorgio La Nasa, Walter Fiedler, Peter Brossart, Bernd Hertenstein, Helmut R Salih, Ombretta Annibali, Mohammed Wattad, Michael Lubbert, Christian H Brandts, Mathias Hanel, Christoph Rollig, Norbert Schmitz, Hartmut Link, Chiara Frairia, Claudio Fozza, Alfonso Maria D'Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Dohner, Arnold Ganser, Hartmut Dohner, Sergio Amadori, Franco Mandelli, Maria Teresa Voso, Gerhard Ehninger, Richard F Schlenk, Francesco Lo-Coco
The value of tumor markers in men with metastatic prostate cancer undergoing [ Lu]Lu-PSMA therapy.
The Prostate
Authors:
Anna Yordanova, Paula Linden, Stefan Hauser, Georg Feldmann, Peter Brossart, Rolf Fimmers, Markus Essler, Stefan Holdenrieder, Hojjat Ahmadzadehfar